According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Computational Medicine and Drug Designing Software Market

The global Computational Medicine and Drug Designing Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Designing Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Designing Software.

Report Scope

The Computational Medicine and Drug Designing Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computational Medicine and Drug Designing Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Computational Medicine and Drug Designing Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Computational Medicine and Drug Designing Software Market Report

Report Metric	Details
Report Name	Computational Medicine and Drug Designing Software Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Cloud-based On-premise
Segment by Application	Drug Discovery and Development Computational Physiological Medicine Disease Modeling Medical Imaging Predictive Analysis of Drug Targets
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos, Leadscope, Rhenovia Pharma Limited, Compugen, Certara LP, Prosarix, Simulations Plus, Strand Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computational Medicine and Drug Designing Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Computational Medicine and Drug Designing Software Market report?

Ans: The main players in the Computational Medicine and Drug Designing Software Market are Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos, Leadscope, Rhenovia Pharma Limited, Compugen, Certara LP, Prosarix, Simulations Plus, Strand Life Sciences

What are the Application segmentation covered in the Computational Medicine and Drug Designing Software Market report?

Ans: The Applications covered in the Computational Medicine and Drug Designing Software Market report are Drug Discovery and Development, Computational Physiological Medicine, Disease Modeling, Medical Imaging, Predictive Analysis of Drug Targets

What are the Type segmentation covered in the Computational Medicine and Drug Designing Software Market report?

Ans: The Types covered in the Computational Medicine and Drug Designing Software Market report are Cloud-based, On-premise

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Cloud-based

1.2.3 On-premise

1.3 Market by Application

1.3.1 Global Computational Medicine and Drug Designing Software Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Drug Discovery and Development

1.3.3 Computational Physiological Medicine

1.3.4 Disease Modeling

1.3.5 Medical Imaging

1.3.6 Predictive Analysis of Drug Targets

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Computational Medicine and Drug Designing Software Market Perspective (2019-2030)

2.2 Computational Medicine and Drug Designing Software Growth Trends by Region

2.2.1 Global Computational Medicine and Drug Designing Software Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Computational Medicine and Drug Designing Software Historic Market Size by Region (2019-2024)

2.2.3 Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2025-2030)

2.3 Computational Medicine and Drug Designing Software Market Dynamics

2.3.1 Computational Medicine and Drug Designing Software Industry Trends

2.3.2 Computational Medicine and Drug Designing Software Market Drivers

2.3.3 Computational Medicine and Drug Designing Software Market Challenges

2.3.4 Computational Medicine and Drug Designing Software Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue

3.1.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue (2019-2024)

3.1.2 Global Computational Medicine and Drug Designing Software Revenue Market Share by Players (2019-2024)

3.2 Global Computational Medicine and Drug Designing Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Computational Medicine and Drug Designing Software Revenue

3.4 Global Computational Medicine and Drug Designing Software Market Concentration Ratio

3.4.1 Global Computational Medicine and Drug Designing Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Designing Software Revenue in 2023

3.5 Computational Medicine and Drug Designing Software Key Players Head office and Area Served

3.6 Key Players Computational Medicine and Drug Designing Software Product Solution and Service

3.7 Date of Enter into Computational Medicine and Drug Designing Software Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Computational Medicine and Drug Designing Software Breakdown Data by Type

4.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2019-2024)

4.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2025-2030)

5 Computational Medicine and Drug Designing Software Breakdown Data by Application

5.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2019-2024)

5.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Computational Medicine and Drug Designing Software Market Size (2019-2030)

6.2 North America Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)

6.4 North America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Computational Medicine and Drug Designing Software Market Size (2019-2030)

7.2 Europe Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)

7.4 Europe Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size (2019-2030)

8.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2019-2024)

8.4 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Computational Medicine and Drug Designing Software Market Size (2019-2030)

9.2 Latin America Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)

9.4 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size (2019-2030)

10.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)

10.4 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Entelos

11.1.1 Entelos Company Detail

11.1.2 Entelos Business Overview

11.1.3 Entelos Computational Medicine and Drug Designing Software Introduction

11.1.4 Entelos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.1.5 Entelos Recent Development

11.2 Crown Bioscience

11.2.1 Crown Bioscience Company Detail

11.2.2 Crown Bioscience Business Overview

11.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Introduction

11.2.4 Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.2.5 Crown Bioscience Recent Development

11.3 Chemical Computing Group

11.3.1 Chemical Computing Group Company Detail

11.3.2 Chemical Computing Group Business Overview

11.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Introduction

11.3.4 Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.3.5 Chemical Computing Group Recent Development

11.4 Nimbus Therapeutics

11.4.1 Nimbus Therapeutics Company Detail

11.4.2 Nimbus Therapeutics Business Overview

11.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Introduction

11.4.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.4.5 Nimbus Therapeutics Recent Development

11.5 Schrodinger

11.5.1 Schrodinger Company Detail

11.5.2 Schrodinger Business Overview

11.5.3 Schrodinger Computational Medicine and Drug Designing Software Introduction

11.5.4 Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.5.5 Schrodinger Recent Development

11.6 Dassault Systemes

11.6.1 Dassault Systemes Company Detail

11.6.2 Dassault Systemes Business Overview

11.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Introduction

11.6.4 Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.6.5 Dassault Systemes Recent Development

11.7 Genedata

11.7.1 Genedata Company Detail

11.7.2 Genedata Business Overview

11.7.3 Genedata Computational Medicine and Drug Designing Software Introduction

11.7.4 Genedata Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.7.5 Genedata Recent Development

11.8 Biognos

11.8.1 Biognos Company Detail

11.8.2 Biognos Business Overview

11.8.3 Biognos Computational Medicine and Drug Designing Software Introduction

11.8.4 Biognos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.8.5 Biognos Recent Development

11.9 Leadscope

11.9.1 Leadscope Company Detail

11.9.2 Leadscope Business Overview

11.9.3 Leadscope Computational Medicine and Drug Designing Software Introduction

11.9.4 Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.9.5 Leadscope Recent Development

11.10 Rhenovia Pharma Limited

11.10.1 Rhenovia Pharma Limited Company Detail

11.10.2 Rhenovia Pharma Limited Business Overview

11.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Introduction

11.10.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.10.5 Rhenovia Pharma Limited Recent Development

11.11 Compugen

11.11.1 Compugen Company Detail

11.11.2 Compugen Business Overview

11.11.3 Compugen Computational Medicine and Drug Designing Software Introduction

11.11.4 Compugen Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.11.5 Compugen Recent Development

11.12 Certara LP

11.12.1 Certara LP Company Detail

11.12.2 Certara LP Business Overview

11.12.3 Certara LP Computational Medicine and Drug Designing Software Introduction

11.12.4 Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.12.5 Certara LP Recent Development

11.13 Prosarix

11.13.1 Prosarix Company Detail

11.13.2 Prosarix Business Overview

11.13.3 Prosarix Computational Medicine and Drug Designing Software Introduction

11.13.4 Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.13.5 Prosarix Recent Development

11.14 Simulations Plus

11.14.1 Simulations Plus Company Detail

11.14.2 Simulations Plus Business Overview

11.14.3 Simulations Plus Computational Medicine and Drug Designing Software Introduction

11.14.4 Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.14.5 Simulations Plus Recent Development

11.15 Strand Life Sciences

11.15.1 Strand Life Sciences Company Detail

11.15.2 Strand Life Sciences Business Overview

11.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Introduction

11.15.4 Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)

11.15.5 Strand Life Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Entelos Inc

Crown Bioscience

Chemical Computing Group

Rhenovia Pharma Limited

List of Tables

Table 1. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cloud-based

Table 3. Key Players of On-premise

Table 4. Global Computational Medicine and Drug Designing Software Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Computational Medicine and Drug Designing Software Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Computational Medicine and Drug Designing Software Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Computational Medicine and Drug Designing Software Market Share by Region (2019-2024)

Table 8. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Computational Medicine and Drug Designing Software Market Share by Region (2025-2030)

Table 10. Computational Medicine and Drug Designing Software Market Trends

Table 11. Computational Medicine and Drug Designing Software Market Drivers

Table 12. Computational Medicine and Drug Designing Software Market Challenges

Table 13. Computational Medicine and Drug Designing Software Market Restraints

Table 14. Global Computational Medicine and Drug Designing Software Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Computational Medicine and Drug Designing Software Market Share by Players (2019-2024)

Table 16. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2023)

Table 17. Ranking of Global Top Computational Medicine and Drug Designing Software Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Computational Medicine and Drug Designing Software Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Computational Medicine and Drug Designing Software Product Solution and Service

Table 21. Date of Enter into Computational Medicine and Drug Designing Software Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Computational Medicine and Drug Designing Software Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2019-2024)

Table 25. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2025-2030)

Table 27. Global Computational Medicine and Drug Designing Software Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Computational Medicine and Drug Designing Software Revenue Market Share by Application (2019-2024)

Table 29. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Computational Medicine and Drug Designing Software Revenue Market Share by Application (2025-2030)

Table 31. North America Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Computational Medicine and Drug Designing Software Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Computational Medicine and Drug Designing Software Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Computational Medicine and Drug Designing Software Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2025-2030) & (US$ Million)

Table 46. Entelos Company Detail

Table 47. Entelos Business Overview

Table 48. Entelos Computational Medicine and Drug Designing Software Product

Table 49. Entelos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 50. Entelos Recent Development

Table 51. Crown Bioscience Company Detail

Table 52. Crown Bioscience Business Overview

Table 53. Crown Bioscience Computational Medicine and Drug Designing Software Product

Table 54. Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 55. Crown Bioscience Recent Development

Table 56. Chemical Computing Group Company Detail

Table 57. Chemical Computing Group Business Overview

Table 58. Chemical Computing Group Computational Medicine and Drug Designing Software Product

Table 59. Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 60. Chemical Computing Group Recent Development

Table 61. Nimbus Therapeutics Company Detail

Table 62. Nimbus Therapeutics Business Overview

Table 63. Nimbus Therapeutics Computational Medicine and Drug Designing Software Product

Table 64. Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 65. Nimbus Therapeutics Recent Development

Table 66. Schrodinger Company Detail

Table 67. Schrodinger Business Overview

Table 68. Schrodinger Computational Medicine and Drug Designing Software Product

Table 69. Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 70. Schrodinger Recent Development

Table 71. Dassault Systemes Company Detail

Table 72. Dassault Systemes Business Overview

Table 73. Dassault Systemes Computational Medicine and Drug Designing Software Product

Table 74. Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 75. Dassault Systemes Recent Development

Table 76. Genedata Company Detail

Table 77. Genedata Business Overview

Table 78. Genedata Computational Medicine and Drug Designing Software Product

Table 79. Genedata Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 80. Genedata Recent Development

Table 81. Biognos Company Detail

Table 82. Biognos Business Overview

Table 83. Biognos Computational Medicine and Drug Designing Software Product

Table 84. Biognos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 85. Biognos Recent Development

Table 86. Leadscope Company Detail

Table 87. Leadscope Business Overview

Table 88. Leadscope Computational Medicine and Drug Designing Software Product

Table 89. Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 90. Leadscope Recent Development

Table 91. Rhenovia Pharma Limited Company Detail

Table 92. Rhenovia Pharma Limited Business Overview

Table 93. Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Product

Table 94. Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 95. Rhenovia Pharma Limited Recent Development

Table 96. Compugen Company Detail

Table 97. Compugen Business Overview

Table 98. Compugen Computational Medicine and Drug Designing Software Product

Table 99. Compugen Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 100. Compugen Recent Development

Table 101. Certara LP Company Detail

Table 102. Certara LP Business Overview

Table 103. Certara LP Computational Medicine and Drug Designing Software Product

Table 104. Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 105. Certara LP Recent Development

Table 106. Prosarix Company Detail

Table 107. Prosarix Business Overview

Table 108. Prosarix Computational Medicine and Drug Designing Software Product

Table 109. Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 110. Prosarix Recent Development

Table 111. Simulations Plus Company Detail

Table 112. Simulations Plus Business Overview

Table 113. Simulations Plus Computational Medicine and Drug Designing Software Product

Table 114. Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 115. Simulations Plus Recent Development

Table 116. Strand Life Sciences Company Detail

Table 117. Strand Life Sciences Business Overview

Table 118. Strand Life Sciences Computational Medicine and Drug Designing Software Product

Table 119. Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)

Table 120. Strand Life Sciences Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Computational Medicine and Drug Designing Software Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Computational Medicine and Drug Designing Software Market Share by Type: 2023 VS 2030

Figure 3. Cloud-based Features

Figure 4. On-premise Features

Figure 5. Global Computational Medicine and Drug Designing Software Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Computational Medicine and Drug Designing Software Market Share by Application: 2023 VS 2030

Figure 7. Drug Discovery and Development Case Studies

Figure 8. Computational Physiological Medicine Case Studies

Figure 9. Disease Modeling Case Studies

Figure 10. Medical Imaging Case Studies

Figure 11. Predictive Analysis of Drug Targets Case Studies

Figure 12. Computational Medicine and Drug Designing Software Report Years Considered

Figure 13. Global Computational Medicine and Drug Designing Software Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Computational Medicine and Drug Designing Software Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Computational Medicine and Drug Designing Software Market Share by Region: 2023 VS 2030

Figure 16. Global Computational Medicine and Drug Designing Software Market Share by Players in 2023

Figure 17. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Computational Medicine and Drug Designing Software Revenue in 2023

Figure 19. North America Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Computational Medicine and Drug Designing Software Market Share by Country (2019-2030)

Figure 21. United States Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Computational Medicine and Drug Designing Software Market Share by Country (2019-2030)

Figure 25. Germany Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Computational Medicine and Drug Designing Software Market Share by Region (2019-2030)

Figure 33. China Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Computational Medicine and Drug Designing Software Market Share by Country (2019-2030)

Figure 41. Mexico Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Computational Medicine and Drug Designing Software Market Share by Country (2019-2030)

Figure 45. Turkey Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Entelos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 48. Crown Bioscience Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 49. Chemical Computing Group Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 50. Nimbus Therapeutics Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 51. Schrodinger Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 52. Dassault Systemes Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 53. Genedata Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 54. Biognos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 55. Leadscope Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 56. Rhenovia Pharma Limited Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 57. Compugen Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 58. Certara LP Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 59. Prosarix Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 60. Simulations Plus Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 61. Strand Life Sciences Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-32H12616

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Co-Packing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13K12891

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Nucleic Acid-based Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27P12567

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Digital Refractometers for Food and Pharmaceutical Industry Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1D13243

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Computational Medicine and Drug Designing Software Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-26E9443

Global Computational Medicine and Drug Designing Software Market Research Report 2024

FEATURED COMPANIES

Computational Medicine and Drug Designing Software Market Size

Computational Medicine and Drug Designing Software Market

Report Scope

Scope of Computational Medicine and Drug Designing Software Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Computational Medicine and Drug Designing Software Market report?

What are the Application segmentation covered in the Computational Medicine and Drug Designing Software Market report?

What are the Type segmentation covered in the Computational Medicine and Drug Designing Software Market report?

FEATURED COMPANIES

RELATED REPORTS